Volume 22, Issue 3, Pages (March 2012)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 1, Pages (January 2014)
Advertisements

Volume 15, Issue 6, Pages (June 2012)
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 9, Issue 5, Pages (May 2006)
Volume 55, Issue 1, Pages (July 2014)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 12, Issue 13, Pages (July 2002)
Volume 12, Issue 10, Pages (September 2015)
Volume 47, Issue 2, Pages (July 2012)
Volume 22, Issue 3, Pages (March 2012)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Volume 44, Issue 3, Pages (November 2011)
Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death  Piyali Mukherjee,
Volume 47, Issue 5, Pages e6 (November 2017)
Volume 28, Issue 2, Pages (August 2015)
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Wenqian Hu, Bingbing Yuan, Harvey F. Lodish  Developmental Cell 
Jianjun Sun, Wu-Min Deng  Developmental Cell 
Exclusion of CD43 from the Immunological Synapse Is Mediated by Phosphorylation- Regulated Relocation of the Cytoskeletal Adaptor Moesin  Jérôme Delon,
Volume 10, Issue 2, Pages (February 2018)
Kenichi Miharada, Valgardur Sigurdsson, Stefan Karlsson  Cell Reports 
Volume 36, Issue 1, Pages (January 2012)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 11, Issue 1, Pages (July 2012)
14-3-3σ Regulates Keratinocyte Proliferation and Differentiation by Modulating Yap1 Cellular Localization  Sumitha A.T. Sambandam, Ramesh B. Kasetti,
Volume 14, Issue 5, Pages (May 2008)
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Volume 13, Issue 6, Pages (June 2013)
Volume 7, Issue 2, Pages (August 2016)
Volume 21, Issue 1, Pages (January 2017)
Volume 43, Issue 5, Pages (November 2015)
Multiple mRNA Decapping Enzymes in Mammalian Cells
Pituitary Tumor-Transforming Gene 1 Enhances Proliferation and Suppresses Early Differentiation of Keratinocytes  Yosuke Ishitsuka, Yasuhiro Kawachi,
Volume 77, Issue 8, Pages (April 2010)
Volume 3, Issue 6, Pages (December 2014)
Volume 7, Issue 1, Pages (January 2008)
c-Src Activates Endonuclease-Mediated mRNA Decay
Role of NF-κB Activity in Apoptotic Response of Keratinocytes Mediated by Interferon-γ, Tumor Necrosis Factor-α, and Tumor-Necrosis-Factor-Related Apoptosis-Inducing.
Kentaro Abe, Masatoshi Takeichi  Neuron 
Essential Role of TGF-β Signaling in Glucose-Induced Cell Hypertrophy
Volume 10, Issue 3, Pages (September 2006)
GRM7 Regulates Embryonic Neurogenesis via CREB and YAP
Volume 16, Issue 6, Pages (June 2009)
Volume 26, Issue 6, Pages (June 2007)
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Volume 12, Issue 4, Pages (April 2007)
Urtzi Garaigorta, Francis V. Chisari  Cell Host & Microbe 
Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small- Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis.
Volume 8, Issue 1, Pages (January 2011)
RLE-1, an E3 Ubiquitin Ligase, Regulates C
Volume 18, Issue 4, Pages (April 2010)
Hung-Chun Chang, Leonard Guarente  Cell 
The PAR-6 Polarity Protein Regulates Dendritic Spine Morphogenesis through p190 RhoGAP and the Rho GTPase  Huaye Zhang, Ian G. Macara  Developmental Cell 
LAT Links the Pre-BCR to Calcium Signaling
Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells  Dario Antonini, Monia T. Russo, Laura.
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 35, Issue 4, Pages (October 2011)
Volume 16, Issue 2, Pages (February 2002)
Transcriptional Regulation of AKT Activation by E2F
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Volume 25, Issue 7, Pages e4 (November 2018)
Volume 16, Issue 5, Pages (May 2009)
Volume 7, Issue 1, Pages (July 2010)
Volume 55, Issue 1, Pages (July 2014)
Volume 33, Issue 1, Pages (July 2010)
Volume 23, Issue 2, Pages (August 2005)
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Volume 7, Issue 6, Pages (June 2014)
Volume 2, Issue 6, Pages (December 2012)
Presentation transcript:

Volume 22, Issue 3, Pages 573-584 (March 2012) Role of RhoA-Specific Guanine Exchange Factors in Regulation of Endomitosis in Megakaryocytes  Yuan Gao, Elenoe Smith, Elmer Ker, Phil Campbell, Ee-chun Cheng, Siying Zou, Sharon Lin, Lin Wang, Stephanie Halene, Diane S. Krause  Developmental Cell  Volume 22, Issue 3, Pages 573-584 (March 2012) DOI: 10.1016/j.devcel.2011.12.019 Copyright © 2012 Elsevier Inc. Terms and Conditions

Developmental Cell 2012 22, 573-584DOI: (10.1016/j.devcel.2011.12.019) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 Endomitosis of MkPs Induced by TPO (A) 2N to 4N Mk endomitosis shows cleavage furrow ingression with subsequent regression, resulting in one 4N cell. (B) 4N to 8N Mk endomitosis showing no apparent cleavage furrow. The figures show overlays of DIC (gray) with green fluorescent H2B-GFP (green) images taken every 5 min. The time of each image relative to the first is indicated in each frame. Developmental Cell 2012 22, 573-584DOI: (10.1016/j.devcel.2011.12.019) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 Active RhoA Is Absent from the Cleavage Furrow during the First Endomitotic Cleavage Mouse primary PreMegE cells were transduced with the RhoA biosensor virus for 48 hr before switching to fresh GM (A) or DM (B). After 8 hr, the RhoA activation pattern throughout mitosis (A) or endomitosis (B) was assessed. The CFP channel indicates biosensor (and RhoA) localization (i, iii, and v). The RhoA activation pattern was ssessed by the RhoA biosensor's FRET/CFP ratio (FRET). The red color in FRET images indicates high RhoA activation (ii, iv, and vi). All images were processed identically. Elapsed time (minutes) with starting time set to zero (0) (8 hr post-TPO administration) is indicated in each picture. Images are representative of at least four similar observations for each condition. Developmental Cell 2012 22, 573-584DOI: (10.1016/j.devcel.2011.12.019) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 3 GEF-H1 and ECT2 Are Downregulated during Mk Differentiation Data shown for freshly sorted (d0) PreMegE and MkP cells from WT mice, as well as PreMegEs cultured in DM for the time indicated. (A) Relative levels of GEF-H1 mRNA are reduced during Mk differentiation. ∗∗∗p < 0.005, versus value of PreMegE day 0. (B) Relative levels of ECT2 mRNA were also decreased. ∗∗∗p < 0.005, versus value of PreMegE day 0. (C) The protein levels of GEF-H1 and ECT2 are reduced with different kinetics as shown by western blotting. Anti-α-tubulin was used as the loading control. Relative protein level of each sample after normalization to tubulin and setting PreMegE level as 1 are indicated above each band. Developmental Cell 2012 22, 573-584DOI: (10.1016/j.devcel.2011.12.019) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 4 GEF-H1 and ECT2 Are Reduced in Endomitotic Mks (A) Cells were stained with anti-GEF-H1 (red), anti-α-tubulin (green), and DAPI. Examples of normal mitosis (i–iii, PreMegEs cultured in GM), 2N to 4N endomitosis (iv–vi), and ≥4N endomitosis (vii–ix) are shown. GEF-H1 protein level is reduced at the 2N to 4N stage of endomitosis and increases at later stages (2 days) of endomitosis. (B) ECT2 protein, stained with anti-ECT2 antibody (red), is clearly detected in PreMegEs undergoing mitosis (i–iii), and at the 2N to 4N stage of endomitosis (iv–vi), but ECT2 levels are reduced at later stages (2 days) of endomitosis (vii–ix). Developmental Cell 2012 22, 573-584DOI: (10.1016/j.devcel.2011.12.019) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 5 Differential Effects of Overexpressing GEF-H1 or ECT2 on Polyploidization of Mks (A–C) PreMegE cells in GM were transduced with retroviral vectors (control and expressing individual GEFs) and cultured for 2 days, then transferred to DM for 3 days before the ploidy of each sample was assessed. (A) Shown is the effect of overexpressing control (GFP) virus, GEF-H1, or ECT2 encoding virus. Ploidy of GFP+ cells in each condition is shown. The percentages of Mks in 2N, 4N, and ≥8N ploidy are indicated. (B) The average ploidy of Mk expressing GFP only (control), GEF-H1, or ECT2 is compared. ∗∗∗p < 0.005, versus control. (C) In this experiment, cells were transduced with two retroviral vectors (one encoding RFP and the other GFP). Controls received vectors encoding only RFP and GFP. GEF-H1 (top, second panel) received GFP control plus GEF-H1-IRES-RFP vectors, ECT2 (top, third panel) received ECT2-IRES-GFP plus control RFP vectors, the fourth panel (top) shows cells transduced with ECT2-IRES-GFP plus GEF-H1-IRES-RFP. Samples in lower panel were transduced with RhoAN19-IRES-GFP together with RFP control (left), GEF-H1-IRES-RFP (middle), or ECT2-IRES-RFP (right). Ploidy is shown for GFP+RFP+ (double-positive) cells. (D) Western blot of HEL cells transduced with the indicated virus validates expression vectors. (E) Overexpression of GEF-H1 also decreases polyploidization of Mks in vivo. CD45.1 BM cells were transduced with control (GFP only) or GEF-H1-IRES-GFP virus, and transplanted into lethally irradiated CD45.2 mice. After 6 weeks, the ploidy of GFP-positive Mks was analyzed. Representative ploidy profiles from GFP+ Mks expressing empty virus or GEF-H1 are shown. (F) Average ploidy of GFP-positive Mks recovered 6 weeks posttransplant. ∗p < 0.05, versus the value of control. Developmental Cell 2012 22, 573-584DOI: (10.1016/j.devcel.2011.12.019) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 6 Downregulation of GEF-H1 Is MKL1 Dependent (A) The relative mRNA level of GEF-H1 is significantly increased in Mkl1−/− Mks, and shows very little decrease with Mk differentiation. WT or Mkl1−/− PreMegEs or MkPs were cultured in DM as indicated. ∗∗∗p < 0.005, versus the corresponding WT control. (B and C) Relative ECT2 mRNA levels are the same for WT and Mkl1−/− cells (B). In both, ECT2 mRNA decreases during Mk differentiation. p > 0.1 for the values of Mkl1−/− versus the corresponding WT control, (C) PreMegEs cultured in GM (mitotic controls, i–iii and vii–ix), and MkPs cultured in TPO-only medium, which induces endomitosis, were immunostained as indicated. Unlike WT MkPs (iv–vi), Mkl1−/− MkPs do not show a loss of GEF-H1 protein level in response to TPO induction (x–xii). (D and E) 293FT cells were transduced with empty vector (−), WT Mkl1 (WT), constitutively active (CA) Mkl1, which lacks the actin binding domain, or dominant-negative (DN) Mkl1, which lacks the transcriptional activation domain but can still heterodimerize with endogenous Mkl1. Overexpression of CA MKL1 significantly reduces endogenous GEF-H1 mRNA (D) and protein (E) levels compared to cells transduced with empty vector (−), WT Mkl1 (WT), and dominant-negative (DN) Mkl1. GAPDH was used as a loading control in (E). ∗∗∗p < 0.005, and ∗∗p < 0.01, versus the value of empty vector (−). (F) Quantitative RT-PCR reveals much higher levels of GEF-H1 and ECT2 mRNA in the 6133 cell line compared to WT PreMegEs with PreMegE value set to 1. Values normalized to 18S RNA (∗∗∗p < 0.005). Developmental Cell 2012 22, 573-584DOI: (10.1016/j.devcel.2011.12.019) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 7 Knockdown of GEF-H1 Restores Polyploidy in Mkl1−/− Mks In Vitro (A) WT or Mkl1−/− PreMegEs were transduced with retrovirus encoding either shRNA-targeting luciferase or GEF-H1, as indicated. After TPO induced differentiation, ploidy was assessed. A representative ploidy plot for each condition is shown. The percentages of Mks in 2N, 4N, 8N, and ≥16N ploidy are indicated. (B) Average ploidy of these samples (∗∗∗p < 0.005). (C) Validation of shRNA-mediated knockdown of GEF-H1 protein in NIH 3T3 cells transduced with the indicated constructs. GFP-positive shRNA-expressing cells were sorted, and analyzed by western blot. GAPDH was used as the loading control. Developmental Cell 2012 22, 573-584DOI: (10.1016/j.devcel.2011.12.019) Copyright © 2012 Elsevier Inc. Terms and Conditions